Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Nirenberg

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
National Cancer Institute Monograph|April 1, 1981
Prognostic factors in the response of primary osteogenic sarcoma to preoperative chemotherapy (high-dose methotrexate with citrovorum factor)H Juergens, C Kosloff, A Nirenberg, et al.
The American Journal of Nursing|April 1, 1985
Short form for short stayG A Bru, C M Viamontes, A Nirenberg, et al.
Cancer Treatment Reports|March 1, 1978
Serum distribution of citrovorum factor and 5-methyltetrahydrofolate following oral and im administration of calcium leucovorin in normal adultsB M Mehta, A L Gisolfi, D J Hutchison, et al.
The Journal of Pediatrics|June 1, 1997
Impaired early growth of infants perinatally infected with human immunodeficiency virus: correlation with viral loadH Pollack, H Glasberg, E Lee, et al.
Journal of Neuro-Oncology|August 10, 2000
Phase II study of combination taxol and estramustine phosphate in the treatment of recurrent glioblastoma multiformeM A Rosenthal, M L Gruber, J Glass, et al.
National Cancer Institute Monograph|April 1, 1981
Osteogenic sarcoma: eight-percent, three-year, disease-free survival with combination chemotherapy (T-7)G Rosen, A Nirenberg, B Caparros, et al.
Cancer Investigation|January 1, 1984
Primary osteogenic sarcoma of the femur: a model for the use of preoperative chemotherapy in high risk malignant tumorsG Rosen, B Caparros, S Groshen, et al.
Cancer|May 1, 1981
Ewing's sarcoma: ten-year experience with adjuvant chemotherapyG Rosen, B Caparros, A Nirenberg, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1983
Primary osteogenic sarcoma: eight-year experience with adjuvant chemotherapyG Rosen, R C Marcove, A G Huvos, et al.
Cancer|September 24, 1999
A phase I/II study of carboplatin combined with hyperfractionated radiotherapy for brainstem gliomasJ Allen, J Siffert, B Donahue, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
National Cancer Institute Monograph|April 1, 1981
Prognostic factors in the response of primary osteogenic sarcoma to preoperative chemotherapy (high-dose methotrexate with citrovorum factor)H Juergens, C Kosloff, A Nirenberg, et al.
The American Journal of Nursing|April 1, 1985
Short form for short stayG A Bru, C M Viamontes, A Nirenberg, et al.
Cancer Treatment Reports|March 1, 1978
Serum distribution of citrovorum factor and 5-methyltetrahydrofolate following oral and im administration of calcium leucovorin in normal adultsB M Mehta, A L Gisolfi, D J Hutchison, et al.
The Journal of Pediatrics|June 1, 1997
Impaired early growth of infants perinatally infected with human immunodeficiency virus: correlation with viral loadH Pollack, H Glasberg, E Lee, et al.
Journal of Neuro-Oncology|August 10, 2000
Phase II study of combination taxol and estramustine phosphate in the treatment of recurrent glioblastoma multiformeM A Rosenthal, M L Gruber, J Glass, et al.
National Cancer Institute Monograph|April 1, 1981
Osteogenic sarcoma: eight-percent, three-year, disease-free survival with combination chemotherapy (T-7)G Rosen, A Nirenberg, B Caparros, et al.
Cancer Investigation|January 1, 1984
Primary osteogenic sarcoma of the femur: a model for the use of preoperative chemotherapy in high risk malignant tumorsG Rosen, B Caparros, S Groshen, et al.
Cancer|May 1, 1981
Ewing's sarcoma: ten-year experience with adjuvant chemotherapyG Rosen, B Caparros, A Nirenberg, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1983
Primary osteogenic sarcoma: eight-year experience with adjuvant chemotherapyG Rosen, R C Marcove, A G Huvos, et al.
Cancer|September 24, 1999
A phase I/II study of carboplatin combined with hyperfractionated radiotherapy for brainstem gliomasJ Allen, J Siffert, B Donahue, et al.
Pageof 5